Opinion
Video
Panelists discuss how the recent FDA-approved treatments for postpartum depression (PPD), including zuranolone and brexanolone , offer new options for rapid symptom relief and improve the management of severe PPD cases.
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.